Mouse VEGF164 Antibody

Catalog # Availability Size / Price Qty
AF-493-NA
AF-493-SP
Best Seller
Detection of Recombinant Human, Mouse, and Rat VEGF by Western Blot.
4 Images
Product Details
Citations (128)
FAQs
Supplemental Products
Reviews (1)

Mouse VEGF164 Antibody Summary

Species Reactivity
Mouse
Specificity
Detects mouse VEGF in ELISAs and Western blots. In Western blots, detection of recombinant mouse (rm) VEGF164, rmVEGF120, rmVEGF188, and recombinant rat VEGF164 is observered but no cross-reactivity with rmVEGF-B167,rmVEGF-B186 , or recombinant human (rh) VEGF165 is observed. In sandwich immunoassays, less than 0.04% cross-reactivity with rhVEGF121, rhVEGF165, and rhVEGF/PlGF is observed.
Source
Polyclonal Goat IgG
Purification
Antigen Affinity-purified
Immunogen
S. frugiperda insect ovarian cell line Sf 21-derived recombinant mouse VEGF164
Ala27-Arg190
Accession # AAA40547
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.
Label
Unconjugated

Applications

Recommended Concentration
Sample
Western Blot
0.1 µg/mL
See below
Immunohistochemistry
5-15 µg/mL
See below

Mouse VEGF Sandwich Immunoassay

Recommended Concentration
Reagent
ELISA Capture (Matched Antibody Pair)
0.2-0.8 µg/mL 

Use in combination with:

Detection Reagent: Mouse VEGF Biotinylated Antibody (Catalog # BAF493)

Standard: Recombinant Mouse VEGF 164 Protein (Catalog # 493-MV)

Neutralization
Measured by its ability to neutralize VEGF164-induced proliferation in HUVEC human umbilical vein endothelial cells. Conn, G. et al. (1990) Proc. Natl. Acad. Sci USA 87:1323. The Neutralization Dose (ND50) is typically <0.15 µg/mL in the presence of 10 ng/mL Recombinant Mouse VEGF164.

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Western Blot Detection of Recombinant Human, Mouse, and Rat VEGF antibody by Western Blot. View Larger

Detection of Recombinant Human, Mouse, and Rat VEGF by Western Blot. Western blot shows 25 ng of Recombinant Human VEGF165(Catalog # 293-VE), Recombinant Mouse VEGF164(Catalog # 493-MV), Recombinant Mouse VEGF120(Catalog # 494-VE), Recombinant Mouse VEGF-B167(Catalog # 2595-VE), Recombinant Mouse VEGF-B 186 (Catalog # 767-VE), Recombinant Mouse VEGF188(Catalog # 7916-MV), and Recombinant Rat VEGF164(Catalog # 564-RV). PVDF Membrane was probed with 0.1 µg/mL of Goat Anti-Mouse VEGF164Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-493-NA) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF109). A specific band was detected for VEGF at approximately 18-27 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 3.

Immunohistochemistry VEGF<sub>164</sub>in Mouse Kidney. View Larger

VEGF164in Mouse Kidney. Vascular Endothelial Growth Factor 164 (VEGF164) was detected in perfusion fixed frozen sections of mouse kidney using Goat Anti-Mouse VEGF164Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-493-NA) at 15 µg/mL overnight at 4 °C. Tissue was stained (red) and counterstained (green). View our protocol for Fluorescent IHC Staining of Frozen Tissue Sections.

Neutralization View Larger

Cell Proliferation Induced by VEGF164 and Neutralization by Mouse VEGF Antibody. Recombinant Mouse VEGF164 (Catalog # 493-MV) stimulates proliferation in HUVEC human umbilical vein endothelial cells in a dose-dependent manner (orange line), as measured by Resazurin (AR002). Proliferation elicited by Recombinant Mouse VEGF164 (10 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Mouse VEGF164 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-493-NA). The ND50 is typically <0.15 µg/mL.

Immunocytochemistry/ Immunofluorescence Detection of Mouse VEGF by Immunocytochemistry/Immunofluorescence View Larger

Detection of Mouse VEGF by Immunocytochemistry/Immunofluorescence Altered expression of VEGF-A following myeloid-specific ablation of NG2. Double immunostaining for VEGF-A (red) and CD31 (green) was used to quantify and localize VEGF-A expression in tumors from control (A–C) and Mac-NG2ko tumors (D–F). Overall expression of VEGF-A increases 3-fold in Mac-NG2ko tumors (G), consistent with the increased HIF-1 alpha expression seen in Fig. 5I. However, VEGF-A in control tumors is highly localized to blood vessels, while vascular VEGF-A in Mac-NG2ko tumors is reduced 3-fold (H). Instead, non-vascular VEGF-A in Mac-NG2ko tumors is increased by a factor of 5 (I). Scale bars = 60 μm. *p < 0.01 compared to controls. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/26137396), licensed under a CC-BY license. Not internally tested by R&D Systems.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Preparation and Storage

Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Loading...
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: VEGF

Vascular Endothelial Growth Factor (VEGF or VEGF-A), also known as Vascular Permeability Factor (VPF), is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the PDGF family that is characterized by the presence of eight conserved cysteine residues and a cystine knot structure. VEGF164 appears to be the most abundant and potent isoform, followed by VEGF120 and VEGF188. Mouse VEGF164 is an approximately 50 kDa molecular weight homodimer sharing 97% aa sequence identity with corresponding regions of rat, 89% with human and porcine, 90% with feline, equine and canine, and 88% with bovine VEGF, respectively. VEGF binds the type I transmembrane receptor tyrosine kinases VEGF R1 (also called Flt-1) and VEGF R2 (Flk-1/KDR) on endothelial cells. Although VEGF affinity is highest for binding to VEGF R1, VEGF R2 appears to be the primary mediator of VEGF angiogenic activity. Human VEGF165 binds the Semaphorin receptor, Neuropilin-1 and promotes complex formation with VEGF R2. VEGF is required during embryogenesis and functions to regulate the proliferation, migration, and survival of endothelial cells. In adults, VEGF functions mainly in wound healing and the female reproductive cycle. Pathologically, it is involved in tumor angiogenesis and vascular leakage. Circulating VEGF levels correlate with disease activity in autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and systemic lupus erythematosus. VEGF is induced by hypoxia and cytokines such as IL-1, IL-6, IL-8, Oncostatin M (OSM) and TNF-alpha.

Long Name
Vascular Endothelial Growth Factor
Entrez Gene IDs
7422 (Human); 22339 (Mouse); 83785 (Rat); 281572 (Bovine); 403802 (Canine); 493845 (Feline); 30682 (Zebrafish)
Alternate Names
MVCD1; VAS; vascular endothelial growth factor A; Vascular permeability factor; Vasculotropin; VEGF; VEGFA; VEGF-A; VEGFMGC70609; VPF; VPFvascular endothelial growth factor

Product Datasheets

You must select a language.

x

Citations for Mouse VEGF164 Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

128 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation
    Authors: Yanqiu Liu, Agnes D. Berendsen, Shidong Jia, Sutada Lotinun, Roland Baron, Napoleone Ferrara et al.
    Journal of Clinical Investigation
  2. SOCS3 in retinal neurons and glial cells suppresses VEGF signaling to prevent pathological neovascular growth
    Authors: Ye Sun, Meihua Ju, Zhiqiang Lin, Thomas W. Fredrick, Lucy P. Evans, Katherine T. Tian et al.
    Science Signaling
  3. Sustained intraocular vascular endothelial growth factor neutralisation does not affect retinal and choroidal vasculature in Ins2Akita diabetic mice
    Authors: Judith Lechner, Jose R Hombrebueno, Edoardo Pedrini, Mei Chen, Heping Xu
    Diabetes and Vascular Disease Research
  4. TPL2 (Therapeutic Targeting Tumor Progression Locus-2)/ATF4 (Activating Transcription Factor-4)/SDF1 alpha (Chemokine Stromal Cell-Derived Factor-alpha ) Axis Suppresses Diabetic Retinopathy
    Authors: De-Wei Lai, Keng-Hung Lin, Wayne Huey-Herng Sheu, Maw-Rong Lee, Chung-Yu Chen, Wen-Jane Lee et al.
    Circulation Research
  5. Poly-l-arginine based materials as instructive substrates for fibroblast synthesis of collagen
    Authors: Hannah C. Bygd, Dana Akilbekova, Adam Muñoz, Kiva D. Forsmark, Kaitlin M. Bratlie
    Biomaterials
  6. Detection and Quantification of Retinal Neovascularization Using BrdU Incorporation
    Authors: Yan Shao, Jianglei Chen, Xiao-Rong Li, Jian-Xing Ma
    Translational Vision Science & Technology
  7. Lymphatic-specific intracellular modulation of receptor tyrosine kinase signaling improves lymphatic growth and function
    Authors: Raghu P. Kataru, Jung Eun Baik, Hyeung Ju Park, Catherine L. Ly, Jinyeon Shin, Noa Schwartz et al.
    Science Signaling
  8. Combination of apolipoprotein-A-I/apolipoprotein-A-I binding protein and anti-VEGF treatment overcomes anti-VEGF resistance in choroidal neovascularization in mice
    Authors: Lingping Zhu, Mackenzie Parker, Nduka Enemchukwu, Megan Shen, Guogang Zhang, Qing Yan et al.
    Communications Biology
  9. A Functional Role for VEGFR1 Expressed in Peripheral Sensory Neurons in Cancer Pain
    Authors: Deepitha Selvaraj, Vijayan Gangadharan, Christoph W. Michalski, Martina Kurejova, Sebastian Stösser, Kshitij Srivastava et al.
    Cancer Cell
  10. Numerical evaluation reveals the effect of branching morphology on vessel transport properties during angiogenesis
    Authors: Fatemeh Mirzapour-Shafiyi, Yukinori Kametani, Takao Hikita, Yosuke Hasegawa, Masanori Nakayama
    PLOS Computational Biology
  11. Inhibition of c-Met Reduces Lymphatic Metastasis in RIP-Tag2 Transgenic Mice
    Authors: Barbara Sennino, Toshina Ishiguro-Oonuma, Brian J. Schriver, James G. Christensen, Donald M. McDonald
    Cancer Research
  12. Three-dimensional imaging of vascular development in the mouse epididymis
    Authors: Damon-Soubeyrand C, Bongiovanni A, Chorfa A et al.
    eLife
  13. VEGF TrapR1R2 suppresses experimental corneal angiogenesis
    Authors: H. B. Oliveira, T. Sakimoto, J. A. D. Javier, D. T. Azar, S. J. Wiegand, S. Jain et al.
    Eur J Ophthalmol
  14. Inhibition of retinal neovascularization by a PEDF-derived nonapeptide in newborn mice subjected to oxygen-induced ischemic retinopathy
    Authors: Nader Sheibani, Ismail S. Zaitoun, Shoujian Wang, Soesiawati R. Darjatmoko, Andrew Suscha, Yong-Seok Song et al.
    Experimental Eye Research
  15. Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors
    Authors: Barbara Sennino, Toshina Ishiguro-Oonuma, Ying Wei, Ryan M. Naylor, Casey W. Williamson, Vikash Bhagwandin et al.
    Cancer Discovery
  16. Photothermal Optical Coherence Tomography of Anti-Angiogenic Treatment in the Mouse Retina Using Gold Nanorods as Contrast Agents
    Authors: Andrew Y. Gordon, Maryse Lapierre-Landry, Melissa C. Skala, John S. Penn
    Translational Vision Science & Technology
  17. Periosteum-derived podoplanin-expressing stromal cells regulate nascent vascularization during epiphyseal marrow development
    Authors: Shogo Tamura, Masato Mukaide, Yumi Katsuragi, Wataru Fujii, Koya Odaira, Nobuaki Suzuki et al.
    Journal of Biological Chemistry
  18. Environmental oxygen regulates astrocyte proliferation to guide angiogenesis during retinal development
    Authors: Robin M. Perelli, Matthew L. O'Sullivan, Samantha Zarnick, Jeremy N. Kay
    Development
  19. In vivo intermittent hypoxia elicits enhanced expansion and neuronal differentiation in cultured neural progenitors
    Authors: Heather H. Ross, Milap S. Sandhu, Tina F. Cheung, Garrett M. Fitzpatrick, Warren J. Sher, Alexander J. Tiemeier et al.
    Experimental Neurology
  20. The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma
    Authors: Y Zhang, X Gao, Y Zhu, D Kadel, H Sun, J Chen, Q Luo, H Sun, L Yang, J Yang, Y Sheng, Y Zheng, K Zhu, Q Dong, L Qin
    J. Exp. Clin. Cancer Res., 2018-04-30;37(1):93.
  21. NG2 proteoglycan-dependent recruitment of tumor macrophages promotes pericyte-endothelial cell interactions required for brain tumor vascularization
    Authors: Fusanori Yotsumoto, Weon-Kyoo You, Pilar Cejudo-Martin, Karolina Kucharova, Kenji Sakimura, William B Stallcup
    OncoImmunology
  22. A tissue injury sensing and repair pathway distinct from host pathogen defense
    Authors: Liu S, Hur YH, Cai X et al.
    Cell
  23. Microvascular endothelial cells engulf myelin debris and promote macrophage recruitment and fibrosis after neural injury
    Authors: Tian Zhou, Yiming Zheng, Li Sun, Smaranda Ruxandra Badea, Yuanhu Jin, Yang Liu et al.
    Nature Neuroscience
  24. Inhibition of TP signaling promotes endometriosis growth and neovascularization
    Authors: Furue, A;Hattori, K;Hosono, K;Tanabe, M;Sato, E;Honda, M;Sekiguchi, K;Ito, Y;Majima, M;Narumiya, S;Kato, K;Amano, H;
    Molecular medicine reports
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  25. Prox1 Suppresses the Proliferation of Breast Cancer Cells via Direct Inhibition of c-Myc Gene Expression
    Authors: Michail, A;Gkikas, D;Stellas, D;Kaltezioti, V;Politis, PK;
    Cells
    Species: Mouse
    Sample Types: Whole Cells
    Applications: ICC
  26. Neural stem and progenitor cells support and protect adult hippocampal function via vascular endothelial growth factor secretion
    Authors: Denninger, JK;Miller, LN;Walters, AE;Hosawi, M;Sebring, G;Rieskamp, JD;Ding, T;Rindani, R;Chen, KS;Senthilvelan, S;Volk, A;Zhao, F;Askwith, C;Kirby, ED;
    bioRxiv : the preprint server for biology
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  27. Vertical Sleeve Gastrectomy Offers Protection against Disturbed Flow-Induced Atherosclerosis in High-Fat Diet-Fed Mice
    Authors: JH Wei, WJ Lee, JL Luo, HL Huang, SC Wang, RH Chou, PH Huang, SJ Lin
    International Journal of Molecular Sciences, 2023-03-16;24(6):.
    Species: Human
    Sample Types: Tissue Homogenates
    Applications: Western Blot
  28. An agonistic anti-Tie2 antibody suppresses the normal-to-tumor vascular transition in the glioblastoma invasion zone
    Authors: E Lee, EA Lee, E Kong, H Chon, M Llaiqui-Co, CH Park, BY Park, NR Kang, JS Yoo, HS Lee, HS Kim, SH Park, SW Choi, D Vestweber, JH Lee, P Kim, WS Lee, I Kim
    Experimental & Molecular Medicine, 2023-02-24;55(2):470-484.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  29. Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage
    Authors: J Huang, Y Mao, Q Li, H Hong, N Tang, X Kang, Y Huang, J Liu, Q Gong, Y Yao, L Li
    Journal of Cellular and Molecular Medicine, 2022-07-21;26(16):4613-4623.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  30. Regenerating glomerular metabolism and function by podocyte pyruvate kinase M2 in diabetic nephropathy
    Authors: J Fu, T Shinjo, Q Li, R St-Louis, K Park, MG Yu, H Yokomizo, F Simao, Q Huang, IH Wu, GL King
    JCI Insight, 2022-03-08;0(0):.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neutralization
  31. Vascular endothelial growth factor-A/vascular endothelial growth factor2 signaling in spinal neurons contributes to bone cancer pain
    Authors: LJ Fan, HM Kan, XT Chen, YY Sun, LP Chen, W Shen
    Molecular pain, 2022-01-01;18(0):1744806922107.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  32. Efficient protein incorporation and release by a jigsaw-shaped self-assembling peptide hydrogel for injured brain regeneration
    Authors: A Yaguchi, M Oshikawa, G Watanabe, H Hiramatsu, N Uchida, C Hara, N Kaneko, K Sawamoto, T Muraoka, I Ajioka
    Nature Communications, 2021-11-19;12(1):6623.
    Species: Mouse
    Sample Types: Protein
    Applications: ELISA Capture
  33. VEGF Contributes to Mesenchymal Stem Cell-Mediated Reversion of Nor1-Dependent Hypertrophy in iPS Cell-Derived Cardiomyocytes
    Authors: D Philipp, M Holthaus, V Basoah, K Pfannkuche, L Suhr, T Wahlers, A Paunel-Gör
    Stem Cells International, 2021-04-10;2021(0):8888575.
    Species: Mouse
    Sample Types: Cell Lysates, Whole Cells
    Applications: Neutralization, Western Blot
  34. PDGF Receptor Alpha Signaling Is Key for M�ller Cell Homeostasis Functions
    Authors: N Díaz-Lezam, A Wolf, S Koch, AM Pfaller, J Biber, X Guillonnea, T Langmann, A Grosche
    International Journal of Molecular Sciences, 2021-01-25;22(3):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  35. Cancer immunotherapy via targeted TGF-&beta signalling blockade in TH cells
    Authors: S Li, M Liu, MH Do, C Chou, EG Stamatiade, BG Nixon, W Shi, X Zhang, P Li, S Gao, KJ Capistrano, H Xu, NV Cheung, MO Li
    Nature, 2020-10-21;0(0):.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  36. Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23
    Authors: PL Mulcrone, SKE Edwards, DN Petrusca, LS Haneline, J Delgado-Ca, GD Roodman
    Sci Rep, 2020-10-14;10(1):17319.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  37. Overexpression of microRNA-367 inhibits angiogenesis in ovarian cancer by downregulating the expression of LPA1
    Authors: Q Zheng, X Dai, W Fang, Y Zheng, J Zhang, Y Liu, D Gu
    Cancer Cell Int, 2020-10-02;20(0):476.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  38. Activated FGF2 signaling pathway in tumor vasculature is essential for acquired resistance to anti-VEGF therapy
    Authors: K Ichikawa, S Watanabe M, Y Minoshima, J Matsui, Y Funahashi
    Sci Rep, 2020-02-19;10(1):2939.
    Species: Mouse
    Sample Types: Cell Lysates
    Applications: Western Blot
  39. Chitinase-3-Like-1 Promotes M2 Macrophage Differentiation and Induces Choroidal Neovascularization in Neovascular Age-Related Macular Degeneration
    Authors: N Xu, Q Bo, R Shao, J Liang, Y Zhai, S Yang, F Wang, X Sun
    Invest. Ophthalmol. Vis. Sci., 2019-11-01;60(14):4596-4605.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  40. Serum miRNAs are potential biomarkers for the detection of disc degeneration, among which miR-26a-5p suppresses Smad1 to regulate disc homeostasis
    Authors: Y Fan, L Zhao, W Xie, D Yi, S He, D Chen, J Huang
    J. Cell. Mol. Med., 2019-07-23;0(0):.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-P
  41. Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury
    Authors: Y Oe, T Fushima, E Sato, A Sekimoto, K Kisu, H Sato, J Sugawara, S Ito, N Takahashi
    Sci Rep, 2019-02-27;9(1):2986.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-P
  42. Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment
    Authors: AD Kolb, AB Shupp, D Mukhopadhy, FC Marini, KM Bussard
    Breast Cancer Res., 2019-02-27;21(1):31.
    Species: Mouse
    Sample Types: Cell Lysates, Whole Tissue
    Applications: IHC, Western Blot
  43. Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC
    Authors: B John, C Naczki, C Patel, A Ghoneum, S Qasem, Z Salih, N Said
    Oncogene, 2019-02-14;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  44. Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina
    Authors: C Balser, A Wolf, M Herb, T Langmann
    J Neuroinflammation, 2019-02-07;16(1):26.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  45. Regeneration-associated cell transplantation contributes to tissue recovery in mice with acute ischemic stroke
    Authors: T Nakayama, E Nagata, H Masuda, T Asahara, S Takizawa
    PLoS ONE, 2019-01-25;14(1):e0210198.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  46. Bone Morphogenetic Protein 9 Regulates Early Lymphatic-Specified Endothelial Cell Expansion during Mouse Embryonic Stem Cell Differentiation
    Authors: M Subileau, G Merdzhanov, D Ciais, V Collin-Fau, JJ Feige, S Bailly, D Vittet
    Stem Cell Reports, 2018-12-27;0(0):.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neutralization
  47. The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice
    Authors: JM Adrian-Seg, K Sreenivasa, P Gajawada, H Lörchner, T Braun, J Pöling
    J. Biol. Chem., 2018-10-29;0(0):.
    Species: Human
    Sample Types: Cell Culture Supernates
    Applications: Western Blot
  48. Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity
    Authors: B Schrand, E Clark, A Levay, AR Capote, O Martinez, R Brenneman, I Castro, E Gilboa
    Nat Commun, 2018-08-22;9(1):3348.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  49. Bushen Huoxue Recipe Alleviates Implantation Loss in Mice by Enhancing Estrogen-Progesterone Signals and Promoting Decidual Angiogenesis Through FGF2 During Early Pregnancy
    Authors: J Ding, X Tan, K Song, W Ma, J Xiao, Y Song, M Zhang
    Front Pharmacol, 2018-05-15;9(0):437.
    Species: Mouse
    Sample Types: Tissue Homogenates, Whole Tissue
    Applications: IHC, Western Blot
  50. Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis
    Authors: T Kobori, S Hamasaki, A Kitaura, Y Yamazaki, T Nishinaka, A Niwa, S Nakao, H Wake, S Mori, T Yoshino, M Nishibori, H Takahashi
    Front Immunol, 2018-03-06;9(0):334.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neutralization
  51. Vascularization via activation of VEGF-VEGFR signaling is essential for peripheral nerve regeneration
    Authors: Y Nishida, Y Yamada, H Kanemaru, A Ohazama, T Maeda, K Seo
    Biomed. Res., 2018-01-01;39(6):287-294.
    Species: Mouse
    Sample Types:
    Applications: Neutralization
  52. Modulation of Salmonella Tumor-Colonization and Intratumoral Anti-angiogenesis by Triptolide and Its Mechanism
    Authors: J Chen, Y Qiao, B Tang, G Chen, X Liu, B Yang, J Wei, X Zhang, X Cheng, P Du, W Jiang, Q Hu, ZC Hua
    Theranostics, 2017-06-01;7(8):2250-2260.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  53. Ferrochelatase is a therapeutic target for ocular neovascularization
    Authors: HD Basavaraja, RS Sulaiman, X Qi, T Shetty, S Sheik Pran, KL Sishtla, B Lee, J Quigley, S Alkhairy, CM Briggs, K Gupta, B Tang, M Shadmand, MB Grant, ME Boulton, SY Seo, TW Corson
    EMBO Mol Med, 2017-06-01;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Functional Assay
  54. Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes
    Authors: T Hara, HJ Nakaoka, T Hayashi, K Mimura, D Hoshino, M Inoue, F Nagamura, Y Murakami, M Seiki, T Sakamoto
    Proc. Natl. Acad. Sci. U.S.A., 2017-05-15;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  55. CYP4A in tumor-associated macrophages promotes pre-metastatic niche formation and metastasis
    Authors: XW Chen, TJ Yu, J Zhang, Y Li, HL Chen, GF Yang, W Yu, YZ Liu, XX Liu, CF Duan, HL Tang, M Qiu, CL Wang, H Zheng, J Yue, AM Guo, J Yang
    Oncogene, 2017-05-08;0(0):.
    Species: Mouse
    Sample Types: Cell Culture Supernates
    Applications: Functional Assay
  56. VEGF as a Paracrine Regulator of Conventional Outflow Facility
    Authors: E Reina-Torr, JC Wen, KC Liu, G Li, JM Sherwood, JY Chang, P Challa, CM Flügel-Koc, WD Stamer, RR Allingham, DR Overby
    Invest. Ophthalmol. Vis. Sci., 2017-03-01;58(3):1899-1908.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  57. A delay in vascularization induces abnormal astrocyte proliferation and migration in the mouse retina
    Authors: Akane Morita
    Dev. Dyn, 2017-02-03;0(0):.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-Fr
  58. The biomechanical properties of an epithelial tissue determine the location of its vasculature
    Nat Commun, 2016-12-20;7(0):13560.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  59. PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently
    Authors: L Zheng, C Zhao, Y Du, X Lin, Y Jiang, C Lee, G Tian, J Mi, X Li, Q Chen, Z Ye, L Huang, S Wang, X Ren, L Xing, W Chen, D Huang, Z Gao, S Zhang, W Lu, Z Tang, B Wang, R Ju, X Li
    Oncotarget, 2016-11-22;7(47):77902-77915.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  60. Intrafibrillar silicified collagen scaffold modulates monocyte to promote cell homing, angiogenesis and bone regeneration
    Authors: Ji-Hua Chen
    Biomaterials, 2016-10-31;113(0):203-216.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neutralization
  61. Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization
    Mol Ther Methods Clin Dev, 2016-08-24;3(0):16056.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  62. Morphine decreases the pro-angiogenic interaction between breast cancer cells and macrophages in vitro
    Sci Rep, 2016-08-12;6(0):31572.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neutralization
  63. Antihypoxic Potentiation of Standard Therapy for Experimental Colorectal Liver Metastasis through Myo-Inositol Trispyrophosphate
    Clin Cancer Res, 2016-08-03;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  64. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy
    Sci Rep, 2016-05-05;6(0):25509.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  65. Endothelial Cords Promote Tumor Initial Growth prior to Vascular Function through a Paracrine Mechanism
    Authors: C Zhao, W Zhang, Y Zhao, Y Yang, H Luo, G Ji, E Dong, H Deng, S Lin, Y Wei, H Yang
    Sci Rep, 2016-01-14;6(0):19404.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  66. HMGB1 induces angiogenesis in rheumatoid arthritis via HIF-1alpha activation.
    Authors: Park S, Lee S, Kim H, Lee W, Hong K, Kim C
    Eur J Immunol, 2015-01-15;45(4):1216-27.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-P
  67. Retinal neurons curb inflammation and enhance revascularization in ischemic retinopathies via proteinase-activated receptor-2.
    Authors: Sitaras N, Rivera J, Noueihed B, Bien-Aime M, Zaniolo K, Omri S, Hamel D, Zhu T, Hardy P, Sapieha P, Joyal J, Chemtob S
    Am J Pathol, 2014-12-03;185(2):581-95.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: Neutralization
  68. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis.
    Authors: Bonapace L, Coissieux M, Wyckoff J, Mertz K, Varga Z, Junt T, Bentires-Alj M
    Nature, 2014-10-22;515(7525):130-3.
    Species: Mouse
    Sample Types: In Vivo
  69. Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis.
    Authors: Lee E, Fertig E, Jin K, Sukumar S, Pandey N, Popel A
    Nat Commun, 2014-09-02;5(0):4715.
    Species: Mouse
    Sample Types: In Vivo, Whole Tissue
    Applications: IHC, Neutralization
  70. Derivation and expansion of PAX7-positive muscle progenitors from human and mouse embryonic stem cells.
    Authors: Shelton M, Metz J, Liu J, Carpenedo R, Demers S, Stanford W, Skerjanc I
    Stem Cell Reports, 2014-08-07;3(3):516-29.
    Species: Mouse
    Sample Types: Cell Culture Supernates
    Applications: IHC
  71. RhoA/phosphatidylinositol 3-kinase/protein kinase B/mitogen-activated protein kinase signaling after growth arrest-specific protein 6/mer receptor tyrosine kinase engagement promotes epithelial cell growth and wound repair via upregulation of hepatocyte growth factor in macrophages.
    Authors: Lee Y, Park H, Woo S, Park E, Kang J
    J Pharmacol Exp Ther, 2014-06-17;350(3):563-77.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neutralization
  72. An inducible hepatocellular carcinoma model for preclinical evaluation of antiangiogenic therapy in adult mice.
    Authors: Runge A, Hu J, Wieland M, Bergeest J, Mogler C, Neumann A, Geraud C, Arnold B, Rohr K, Komljenovic D, Schirmacher P, Goerdt S, Augustin H
    Cancer Res, 2014-06-06;74(15):4157-69.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-P
  73. Granzyme B releases vascular endothelial growth factor from extracellular matrix and induces vascular permeability.
    Authors: Hendel, Alon, Hsu, Ivy, Granville, David J
    Lab Invest, 2014-05-05;94(7):716-25.
    Species: Mouse
    Sample Types: In Vivo, Whole Tissue
    Applications: IHC, IHC-P, Neutralization
  74. Angiopoietin-1 suppresses choroidal neovascularization and vascular leakage.
    Authors: Lee, Junyeop, Park, Dae-Youn, Park, Do Young, Park, Intae, Chang, Woohyok, Nakaoka, Yoshikaz, Komuro, Issei, Yoo, Ook-Joon, Koh, Gou Youn
    Invest Ophthalmol Vis Sci, 2014-04-07;55(4):2191-9.
    Species: Mouse
    Sample Types: Tissue Homogenates, Whole Tissue
    Applications: IHC, Western Blot
  75. Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) in the brain.
    Authors: Yu S, Levi L, Casadesus G, Kunos G, Noy N
    J Biol Chem, 2014-03-18;289(18):12748-58.
    Species: Mouse
    Sample Types: Cell Lysates
    Applications: Western Blot
  76. Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.
    Authors: Locatelli M, Buelli S, Pezzotta A, Corna D, Perico L, Tomasoni S, Rottoli D, Rizzo P, Conti D, Thurman J, Remuzzi G, Zoja C, Morigi M
    J Am Soc Nephrol, 2014-02-27;25(8):1786-98.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  77. Dendritic cells: In vitro culture in two- and three-dimensional collagen systems and expression of collagen receptors in tumors and atherosclerotic microenvironments.
    Authors: Sprague L, Muccioli M, Pate M, Singh M, Xiong C, Ostermann A, Niese B, Li Y, Li Y, Courreges M, Benencia F
    Exp Cell Res, 2014-02-22;323(1):7-27.
    Species: Mouse
    Sample Types: Cell Culture Supernates
    Applications: ELISA Development (Detection)
  78. IKK2 inhibition attenuates laser-induced choroidal neovascularization.
    Authors: Lu H, Lu Q, Gaddipati S, Kasetti R, Wang W, Pasparakis M, Kaplan H, Li Q
    PLoS ONE, 2014-01-28;9(1):e87530.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  79. Folic acid mitigates angiotensin-II-induced blood pressure and renal remodeling.
    Authors: Pushpakumar, Sathnur, Kundu, Sourav, Metreveli, Naira, Sen, Utpal
    PLoS ONE, 2013-12-26;8(12):e83813.
    Species: Mouse
    Sample Types: Tissue Homogenates
    Applications: Western Blot
  80. Endothelial lineage differentiation from induced pluripotent stem cells is regulated by microRNA-21 and transforming growth factor beta2 (TGF-beta2) pathways.
    Authors: Di Bernardini E, Campagnolo P, Margariti A, Zampetaki A, Karamariti E, Hu Y, Xu Q
    J Biol Chem, 2013-12-19;289(6):3383-93.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neutralization
  81. MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain.
    Authors: Zeng, L, He, X, Wang, Y, Tang, Y, Zheng, C, Cai, H, Liu, J, Wang, Y, Fu, Y, Yang, G-Y
    Gene Ther, 2013-10-24;21(1):37-43.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  82. Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF-A bioavailability and secreting VEGF-D.
    Authors: Tan K, Chong S, Wong F, Evrard M, Tan S, Keeble J, Kemeny D, Ng L, Abastado J, Angeli V
    Blood, 2013-10-10;122(22):3666-77.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  83. IL-18 regulates melanoma VLA-4 integrin activation through a Hierarchized sequence of inflammatory factors.
    Authors: Valcarcel M, Carrascal T, Crende O, Vidal-Vanaclocha F
    J Invest Dermatol, 2013-08-12;134(2):470-80.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neutralization
  84. G protein-coupled receptor kinase 6 deficiency promotes angiogenesis, tumor progression, and metastasis.
    Authors: Raghuwanshi S, Smith N, Rivers E, Thomas A, Sutton N, Hu Y, Mukhopadhyay S, Chen X, Leung T, Richardson R
    J Immunol, 2013-04-15;190(10):5329-36.
    Species: Mouse
    Sample Types: Tissue Homogenates
    Applications: ELISA Development (Capture)
  85. The role of IL-1beta in the early tumor cell-induced angiogenic response.
    Authors: Carmi Y, Dotan S, Rider P, Kaplanov I, White M, Baron R, Abutbul S, Huszar M, Dinarello C, Apte R, Voronov E
    J Immunol, 2013-03-08;190(7):3500-9.
    Species: Mouse
    Sample Types: In Vivo, Matrigel Plug
    Applications: IHC-Fr, Neutralization
  86. Inhibition of PAI-1 induces neutrophil-driven neoangiogenesis and promotes tissue regeneration via production of angiocrine factors in mice.
    Blood, 2012-05-09;119(26):6382-93.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  87. Response patterns of cytokines/chemokines in two murine strains after irradiation.
    Authors: Zhang M, Yin L, Zhang K, Sun W, Yang S, Zhang B, Salzman P, Wang W, Liu C, Vidyasagar S, Zhang L, Ju S, Okunieff P, Zhang L
    Cytokine, 2012-01-25;58(2):169-77.
    Species: Mouse
    Sample Types: Plasma
    Applications: Luminex Development
  88. Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization.
    Authors: Liu J, Jha P, Lyzogubov VV, Tytarenko RG, Bora NS, Bora PS
    J. Biol. Chem., 2011-04-22;286(23):20991-1001.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  89. IL-17 and VEGF are necessary for efficient corneal nerve regeneration.
    Authors: Li Z, Burns AR, Han L, Rumbaut RE, Smith CW
    Am. J. Pathol., 2011-03-01;178(3):1106-16.
    Species: Mouse
    Sample Types: In Vivo, Whole Tissue
    Applications: IHC-Fr, Neutralization
  90. Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway.
    Authors: Furrer K, Rickenbacher A, Tian Y, Jochum W, Bittermann AG, Kach A, Humar B, Graf R, Moritz W, Clavien PA
    Proc. Natl. Acad. Sci. U.S.A., 2011-01-31;108(7):2945-50.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  91. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction.
    Authors: Jujo K, Hamada H, Iwakura A, Thorne T, Sekiguchi H, Clarke T, Ito A, Misener S, Tanaka T, Klyachko E, Kobayashi K, Tongers J, Roncalli J, Tsurumi Y, Hagiwara N, Losordo DW
    Proc. Natl. Acad. Sci. U.S.A., 2010-06-01;107(24):11008-13.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  92. Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomas.
    Authors: Lederle W, Linde N, Heusel J, Bzyl J, Woenne EC, Zwick S, Skobe M, Kiessling F, Fusenig NE, Mueller MM
    Am. J. Pathol., 2009-12-30;176(2):981-94.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: ICC
  93. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.
    Authors: Wuest TR, Carr DJ
    J. Exp. Med., 2009-12-21;207(1):101-15, S1-2.
    Species: Mouse
    Sample Types: In Vivo, Whole Tissue
    Applications: IHC, Neutralization
  94. Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease.
    Authors: Hakroush S, Moeller MJ, Theilig F, Kaissling B, Sijmonsma TP, Jugold M, Akeson AL, Traykova-Brauch M, Hosser H, Hahnel B, Grone HJ, Koesters R, Kriz W
    Am. J. Pathol., 2009-10-15;175(5):1883-95.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-P
  95. Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution.
    Authors: Kataru RP, Jung K, Jang C, Yang H, Schwendener RA, Baik JE, Han SH, Alitalo K, Koh GY
    Blood, 2009-04-03;113(22):5650-9.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  96. Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1.
    Authors: Shen HC, He M, Powell A, Adem A, Lorang D, Heller C, Grover AC, Ylaya K, Hewitt SM, Marx SJ, Spiegel AM, Libutti SK
    Cancer Res., 2009-02-10;69(5):1858-66.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-Fr, IHC-P
  97. Safety profile of topical VEGF neutralization at the cornea.
    Authors: Bock F, Onderka J, Rummelt C, Dietrich T, Bachmann B, Kruse FE, Schlotzer-Schrehardt U, Cursiefen C
    Invest. Ophthalmol. Vis. Sci., 2009-01-17;50(5):2095-102.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: Blocking
  98. Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1.
    Authors: Ponticelli S, Marasco D, Tarallo V, Albuquerque RJ, Mitola S, Takeda A, Stassen JM, Presta M, Ambati J, Ruvo M, De Falco S
    J. Biol. Chem., 2008-10-15;283(49):34250-9.
    Species: Mouse
    Sample Types: Recombinant Protein
    Applications: ELISA Development
  99. Fibroblast-type reticular stromal cells regulate the lymph node vasculature.
    Authors: Chyou S, Ekland EH, Carpenter AC, Tzeng TC, Tian S, Michaud M, Madri JA, Lu TT
    J. Immunol., 2008-09-15;181(6):3887-96.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  100. Role of cell and matrix-bound VEGF isoforms in lens development.
    Authors: Saint-Geniez M, Kurihara T, D'Amore PA
    Invest. Ophthalmol. Vis. Sci., 2008-08-29;50(1):311-21.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neutralization
  101. Regulation of scar formation by vascular endothelial growth factor.
    Authors: Wilgus TA, Ferreira AM, Oberyszyn TM, Bergdall VK, DiPietro LA
    Lab. Invest., 2008-04-21;88(6):579-90.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  102. Loss of vascular endothelial growth factor expression reduces vascularization, but not growth, of tumors lacking the Von Hippel-Lindau tumor suppressor gene.
    Authors: Blouw B, Haase VH, Song H, Bergers G, Johnson RS
    Oncogene, 2007-02-05;26(31):4531-40.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  103. Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells.
    Authors: Lederle W, Stark HJ, Skobe M, Fusenig NE, Mueller MM
    Am. J. Pathol., 2006-11-01;169(5):1767-83.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  104. Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function.
    Authors: Kajiya K, Hirakawa S, Detmar M
    Am. J. Pathol., 2006-10-01;169(4):1496-503.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  105. The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta.
    Authors: Shchors K, Shchors E, Rostker F, Lawlor ER, Brown-Swigart L, Evan GI
    Genes Dev., 2006-09-15;20(18):2527-38.
    Species: Mouse
    Sample Types: Cell Culture Supernates
    Applications: ELISA Development
  106. Mast cells facilitate local VEGF release as an early event in the pathogenesis of postoperative peritoneal adhesions.
    Authors: Cahill RA, Wang JH, Soohkai S, Redmond HP
    Surgery, 2006-07-01;140(1):108-12.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  107. VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain.
    Authors: Le Bras B, Barallobre MJ, Homman-Ludiye J, Ny A, Wyns S, Tammela T, Haiko P, Karkkainen MJ, Yuan L, Muriel MP, Chatzopoulou E, Breant C, Zalc B, Carmeliet P, Alitalo K, Eichmann A, Thomas JL
    Nat. Neurosci., 2006-02-05;9(3):340-8.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC-Fr
  108. Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A.
    Authors: Nozaki M, Sakurai E, Raisler BJ, Baffi JZ, Witta J, Ogura Y, Brekken RA, Sage EH, Ambati BK, Ambati J
    J. Clin. Invest., 2006-02-01;116(2):422-9.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  109. Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects.
    Authors: Kim B, Lee S, Suvas S, Rouse BT
    J. Immunol., 2005-07-01;175(1):509-16.
    Species: Mouse
    Sample Types: Cell Lysates
    Applications: ELISA Development
  110. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.
    Authors: Dikov MM, Ohm JE, Ray N, Tchekneva EE, Burlison J, Moghanaki D, Nadaf S, Carbone DP
    J. Immunol., 2005-01-01;174(1):215-22.
    Species: Mouse
    Sample Types: Cell Lysates
    Applications: Neutralization
  111. Vascular endothelial growth factor (VEGF) gene transfer enhances surgical revascularization of necrotic bone.
    Authors: Katsube K, Bishop AT, Simari RD, Yla-Herttuala S, Friedrich PF
    J. Orthop. Res., 2004-11-30;23(2):469-74.
    Species: Rabbit
    Sample Types: Whole Tissue
    Applications: IHC
  112. CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization.
    Authors: Banerjee K, Biswas PS, Kim B, Lee S, Rouse BT
    J. Immunol., 2004-01-15;172(2):1237-45.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  113. Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice.
    Authors: Kodama I, Sanada M, Yoshiko Y, Tsuda M, Ohama K
    J. Bone Miner. Res., 2003-12-16;19(2):200-6.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  114. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction.
    Authors: Kozawa O, Yoshimi N, Akamatsu S, Hara A, Mori H, Uematsu T
    Blood, 2002-10-01;100(7):2487-93.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  115. Plumbagin inhibits tumor angiogenesis of gastric carcinoma in mice by modulating nuclear factor-kappa B pathway
    Authors: Chengqian Yang, Xingbo Feng, Zengxian Li, Qingsi He
    Translational Cancer Research
  116. Application of recombinant peroxisome proliferator-activated receptor-gamma coactivator-1 alpha mediates neovascularization in the retina
    Authors: JIAN JIANG, LIXIN ZHANG, LU ZHANG, XIAOBO XIA
    Molecular Medicine Reports
  117. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.
    Authors: Gabrilovich DI, 2018, Ishida T, Nadaf S, Ohm JE, Carbone DP
    1537, 1999-10-01;5(10):2963-70.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  118. Pro-Resolving Factors Released by Macrophages After Efferocytosis Promote Mucosal Wound Healing in Inflammatory Bowel Disease
    Authors: Omayra Martin-Rodriguez, Thierry Gauthier, Francis Bonnefoy, Mélanie Couturier, Anna Daoui, Cécile Chagué et al.
    Frontiers in Immunology
  119. Sustained intraocular VEGF neutralization results in retinal neurodegeneration in the Ins2(Akita) diabetic mouse
    Authors: Jose R. Hombrebueno, Imran HA. Ali, Heping Xu, Mei Chen
    Scientific Reports
  120. Sevoflurane promotes the proliferation of HUVECs by activating VEGF signaling
    Authors: Zengtao Wang, Cui Wu, Min Zhang, Aiping Dong, Ruibin Niu, Jie Zhang
    Experimental and Therapeutic Medicine
  121. The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells
    Authors: Leslee Sprague, Maria Muccioli, Michelle Pate, Evan Meles, John McGinty, Harika Nandigam et al.
    BMC Immunology
  122. Production of the cytokine VEGF-A by infiltrating CD4+ T and myeloid cells disrupts the corneal nerve landscape and promotes herpes stromal keratitis
    Authors: Hongmin Yun, Michael B. Yee, Kira L. Lathrop, Paul R. Kinchington, Robert L. Hendricks, Anthony J. St. Leger
    Immunity
  123. Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization
    Authors: Nader Sheibani, Shoujian Wang, Soesiawati R. Darjatmoko, Debra L. Fisk, Pawan K. Shahi, Bikash R. Pattnaik et al.
    Experimental Eye Research
  124. Experimental and theoretical investigation of the precise transduction mechanism in giant magnetoresistive biosensors
    Authors: Jung-Rok Lee, Noriyuki Sato, Daniel J. B. Bechstein, Sebastian J. Osterfeld, Junyi Wang, Adi Wijaya Gani et al.
    Scientific Reports
  125. Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy
    Authors: JH Wu, YN Li, AQ Chen, CD Hong, CL Zhang, HL Wang, YF Zhou, PC Li, Y Wang, L Mao, YP Xia, QW He, HJ Jin, ZY Yue, B Hu
    EMBO Mol Med, 2020-01-13;12(2):e10154.
  126. Methylation-dependent regulation of HIF-1alpha stability restricts retinal and tumour angiogenesis.
    Authors: Kim Y, Nam HJ, Lee J et al.
    Nat Commun
  127. Midkine Controls Arteriogenesis by Regulating the Bioavailability of Vascular Endothelial Growth Factor A and the Expression of Nitric Oxide Synthase 1 and 3
    Authors: Thomas Lautz, Manuel Lasch, Julia Borgolte, Kerstin Troidl, Judith-Irina Pagel, Amelia Caballero-Martinez et al.
    EBioMedicine
  128. Adhesion to substrates induces dendritic cell endothelization and decreases immunological response
    Authors: Jacob Osterbur, Leslee Sprague, Maria Muccioli, Michelle Pate, Kristen Mansfield, John McGinty et al.
    Immunobiology

FAQs

  1. What band size(s) are detected when using AF-493-NA for Western blot?

    • This antibody detects Recombinant Mouse VEGF164 at 42 kDa under non-reducing conditions and 21 kDa under reducing conditions.  Band sizes with natural samples may vary slightly depending on any post-translational modifications.  

View all Antibody FAQs
Loading...

Reviews for Mouse VEGF164 Antibody

Average Rating: 5 (Based on 1 Review)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Mouse VEGF164 Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Mouse VEGF164 Antibody
By Leslie Priddy on 04/01/2018
Application: WB Sample Tested: Tumor cell lyastes Species: Mouse